Skip to main content
. 2025 Oct 21;17(20):3387. doi: 10.3390/cancers17203387
MM mammography
BT breast tomosynthesis
US breast ultrasound
MRI magnetic resonance imaging
AI artificial intelligence
CESM contrast-enhanced spectral mammography
DL deep learning
CNN convolutional neural networks
ROI region of interest
ALN axillary lymph node
pCR pathological complete response
ER estrogen receptor
PR progesterone receptor
HER2 human epidermal growth factor receptor 2
IHC immunohistochemistry
TN triple-negative
DCIS ductal carcinoma in situ